Pen kit box
From $118.40
- What you get
- The reusable pen, 1 dual-chamber vial, 12 needles and a booklet, in the VETUD box
- BAC water
- Included, in the cartridge
3 / 5
VTD-SS31 · Energy & metabolism
Mitochondria-targeted peptide (elamipretide) studied in energy research.
$118.40
Regular price $148.00
20% offPen kit box · 10 mg
Free standard shipping on orders over $200
Choose a format
Amount
In the box · Pen kit box
VETUD box with the reusable pen body, 1 dual-chamber vial (lyophilized peptide in one chamber, bacteriostatic water in the other), 12 disposable needles and an instruction booklet
All Products listed on this site are for research purposes only. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
The first approved medicine that targets the mitochondria, the cell’s power plants.
Approved in the US in September 2025 (as Forzinity) for Barth syndrome, a rare inherited disease. It is an accelerated approval, which means a further trial must confirm the benefit.
SS-31 is a small four-building-block peptide that travels into mitochondria, the parts of our cells that make energy.
It binds to the inner membrane of mitochondria and helps them keep their structure and work properly.
FDA grants accelerated approval for first treatment for Barth syndrome ↗
US Food and Drug Administration · September 2025
Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results ↗
Thompson et al. · Genetics in Medicine · 2024
Scientific background concerns the named molecule. Batch composition and analytical results must be established from the product documentation. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
SKUVTD-SS31-VIAL-10MG, VTD-SS31-PEN-10MG, VTD-SS31-BOX-10MG, VTD-SS31-VIAL-50MG, VTD-SS31-PEN-50MG, VTD-SS31-BOX-50MG
Follow the storage conditions supplied on the batch label and certificate.
Keep the material in its original, sealed packaging. Follow your laboratory’s handling procedures and the supplied product documentation.
Refer to the lot-specific expiry date and stability documentation. Shelf life should not be inferred from the product name alone.
For solvent compatibility or preparation specifications, request the manufacturer’s batch documentation. Research protocols should be established by qualified laboratory personnel.
Every product comes three ways. It's the same peptide and the same amounts; what changes is the packaging, what's included and the price. Start with the pen kit box, which has the reusable pen, then refill it with dual-chamber vials.
From $118.40
From $86.40
From $46.40
The freeze-dried peptide and the bacteriostatic (BAC) water sit in separate chambers, divided by a rubber stopper. They stay apart until the cartridge is used.
The pen kit box has the reusable pen body with a dual-chamber vial, 12 disposable needles and a booklet. The drive, dial and indicator window stay with the pen: when a cartridge is empty, fit a new dual-chamber vial.
Choose the vial if you already have bacteriostatic water and your own lab supplies. It's the lowest price for the same amount.
Related
Small-molecule NNMT inhibitor studied in cell metabolism research.
Pen kit box / Dual-chamber vial / Vial · 10 mg / 50 mg
From$48.00regular price $60.00
AvailableAll Products listed on this site are for research purposes only
The body's main antioxidant tripeptide, studied in oxidative-stress research.
Pen kit box / Dual-chamber vial / Vial · 600 mg / 1500 mg
From$52.80regular price $66.00
AvailableAll Products listed on this site are for research purposes only
Mitochondria-derived peptide studied in metabolism and ageing research.
Pen kit box / Dual-chamber vial / Vial · 10 mg / 40 mg
From$37.60regular price $47.00
AvailableAll Products listed on this site are for research purposes only
Education
Plain-language guides, news about new studies and selected videos from doctors and researchers. Published studies are about the named compound; they don't establish the safety or performance of this research product.
Energy & metabolism
Elamipretide, Forzinity
The first approved medicine that targets the mitochondria, the cell’s power plants.
StudyEnergy & metabolism
Elamipretide (Forzinity) won accelerated FDA approval for Barth syndrome in September 2025, based on leg-muscle strength. A further trial must confirm the benefit.
Khan Academy
A foundation for reading mitochondrial research. It does not demonstrate a benefit from any experimental compound.
Biology education
Related biology
Background on mitochondria and cellular energy for understanding SS-31. It does not demonstrate benefits of this compound or formulation.
Progress, Potential, and Possibilities
A leading NAD scientist on what the molecule does and what boosting it might achieve.
Interview with Charles Brenner, PhD, NAD researcher at City of Hope
Related biology
Background on NAD metabolism for understanding SS-31. It does not demonstrate benefits of this compound or formulation.